Top 24 Akari Therapeutics investors
The most complete profiles first. Showing 24 of 24.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Albert ChaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more
Verified email available
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Mahendra ShahVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nathan DauVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Qi ZhuVerified
Venture Capital, Private Equity Firm · China
Health CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Verified email available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Frank Kung
Venture Capital, Founder, Private Equity Firm · United States
Series BHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more
Contact details available
James Flynn
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more
Contact details available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Andrew Goldberg
Venture Capital, Private Equity Firm · United States
Health CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Avi Kometz
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Nina Feng
Venture Capital, Private Equity Firm · Taiwan
Health CareHospitalsWomen FoundedRoboticsPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Shan Fu
Venture Capital, Private Equity Firm · China
Health CareHospitalsWomen FoundedInvestment ManagementPortfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more
Contact details available
Ray Prudo
Angel/Individual
Health CareAutoimmune DiseasesBiotechnologyTherapeuticsPortfolio: Akari Therapeutics
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Akari Therapeutics investors are on Angel Roster?
Angel Roster lists 24 Akari Therapeutics investors. 14 of them (58%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Private Equity Firms (15) and Hedge Funds (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Akari Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (8) and Series B (7).
Where are Akari Therapeutics investors based?
Most are based in the United States (19), China (2) and the United Kingdom (1).
Which companies have Akari Therapeutics investors backed?
The most-backed portfolio companies among them are REGENXBIO (23), Homology Medicines (16), SentreHEART (16), Verona Pharma (15) and Olema Oncology (15).
How do I contact Akari Therapeutics investors?
Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.